Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Spring Bank Pharmaceuticals
company
About
Spring Bank Pharmaceuticals is a discovery company developing a new class of pharmaceuticals called small molecule nucleic acid hybrids.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3.90M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2002
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Spring Bank Pharmaceuticals is an IND-stage drug discovery company. Based on its proprietary platform technology, the company is developing a pipeline of products representing a new class of pharmaceuticals they call small molecule nucleic acid hybrids with a wide range of applications and multi-billion dollar market potential.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3.90M
Spring Bank Pharmaceuticals has raised a total of
$3.90M
in funding over 2 rounds. Their latest funding was raised on
May 5, 2011 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 5, 2011 | Grant | $3.90M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Spring Bank Pharmaceuticals is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
